Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
Summary:
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
Contents:; Shaping Public Health through Research and Practice -- Framing the Research Question -- Ethical Standards and Practice for Public Health Research -- Community-Based Participatory Research -- Qualitative Research Methods for Public Health -- Observational Research Designs -- Experimental …
c.1 BC Cancer Agency KEL Library | Available |
Full conference information obtained from the Annual cancer conference program and abstracts. See ID# 15548. (QZ200 B366 2006); Treating early breast cancer : BC Cancer Agency policies by Dr. Susan Ellard (25 minutes); Evolution in funding new cancer drugs by Dr. Susan O'Reilly (25 minutes)
c.1 BC Cancer Agency VAN Library AV Room | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library AV Room | Available |
Summary:; "This compilation attempts to provide readers with brief and concise information on different types of cancer, their origins, and available treatment options. Protein kinase inhibitors, currently in clinical practice and under research for potential clinical usefulness, are also reviewed.…